XHS - ETF AI Analysis
Top Page
SPDR S&P Health Care Services ETF (XHS)
Rating:66Neutral
Price Target:―
Positive Factors
Strong Recent Performance
The ETF has delivered strong gains so far this year and over the past few months, showing solid recent momentum.
Broad Health Care Services Exposure
Most of the fund is invested in health care services companies, giving focused exposure to a key part of the health care sector while still holding a small mix of other industries.
Multiple Strong-Performing Top Holdings
Several of the largest positions, such as Acadia Healthcare, Hinge Health, and Lifestance Health Group, have posted strong year-to-date gains that support the fund’s overall performance.
Negative Factors
Single-Country Concentration
Almost all assets are invested in U.S. companies, which limits international diversification and ties the fund closely to the U.S. market.
Sector Concentration Risk
With the vast majority of assets in health care, the ETF is vulnerable to sector-specific risks such as regulatory changes or reimbursement pressures.
Mixed Performance Among Top Holdings
A few key holdings, including US Physical Therapy and Tenet Healthcare, have shown weaker year-to-date performance, which could drag on overall returns if the trend continues.
XHS vs. SPDR S&P 500 ETF (SPY)
AUM222.23M
RegionNorth America
Expense Ratio0.35%
Beta0.60
IssuerSPDR
Inception DateSep 28, 2011
Dividend Yield0.2%
Asset ClassEquity
Index TrackedS&P Health Care Services Select Industry
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume17,257
30 Day Avg. Volume28,058
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
160.50Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering60
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
XHS Summary
XHS is the SPDR S&P Health Care Services ETF, which follows the S&P Health Care Services Select Industry Index. It focuses on U.S. companies that provide medical care, such as hospitals, home health services, and specialty clinics. Holdings include well-known names like Tenet Healthcare and NeoGenomics. Someone might invest in XHS to gain diversified exposure to the health care services theme, which can benefit from an aging population and steady demand for medical care. A key risk is that health care stocks can still go up and down with the overall stock market and changes in health care regulations.
How much will it cost me?The SPDR S&P Health Care Services ETF (XHS) has an expense ratio of 0.35%, meaning you’ll pay $3.50 per year for every $1,000 invested. This is slightly higher than average for ETFs because it is a sector-focused fund, which typically requires more active management compared to broad-market index funds.
What would affect this ETF?The SPDR S&P Health Care Services ETF (XHS) could benefit from increasing demand for health care services driven by an aging population and advancements in medical technology, which support innovation and growth in its top holdings like NeoGenomics and Guardant Health. However, potential risks include regulatory changes or shifts in government health care policies that could impact profitability, as well as broader economic conditions that may affect consumer spending on health care services. With its strong focus on U.S.-based health care providers, the ETF is well-positioned to capitalize on the sector's resilience but remains sensitive to policy and economic fluctuations.
XHS Top 10 Holdings
XHS is essentially a bet on U.S. health care providers, with hospital operator Tenet Healthcare and fast-rising names like Hinge Health, Lifestance Health, NeoGenomics, and Aveanna setting the pace. These growth-focused stocks have been climbing steadily, giving the fund a strong tailwind, even if their profitability is still a work in progress. GeneDx is more of a wild card, with mixed year-to-date results despite recent momentum, while steadier players like Addus Homecare help balance the ride. Overall, it’s a concentrated play on U.S. health care services rather than broad health care.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Lifestance Health Group | 2.63% | $5.84M | $4.86B | 137.06% | 61 Neutral | |
| GeneDx Holdings | 2.59% | $5.75M | $2.56B | -35.12% | 68 Neutral | |
| Tenet Healthcare | 2.57% | $5.72M | $21.34B | 35.10% | 74 Outperform | |
| NeoGenomics | 2.49% | $5.54M | $2.23B | 117.79% | 55 Neutral | |
| Hinge Health, Inc. Class A | 2.35% | $5.23M | $7.45B | 67.73% | 70 Outperform | |
| Concentra Group Holdings Parent, Inc. | 2.09% | $4.64M | $4.40B | 49.28% | 66 Neutral | |
| Radnet | 2.06% | $4.59M | $5.80B | 3.22% | 63 Neutral | |
| Aveanna Healthcare Holdings | 2.06% | $4.58M | $2.96B | 65.21% | 58 Neutral | |
| Addus Homecare | 2.05% | $4.56M | $2.22B | 4.89% | 74 Outperform | |
| PACS Group Inc | 2.02% | $4.49M | $6.73B | 280.48% | 66 Neutral |
XHS Technical Analysis
Positive
―
Price Trends
134.74
Positive
124.48
Positive
115.54
Positive
Market Momentum
0.63
Positive
52.95
Neutral
51.81
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For XHS, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 135.38, equal to the 50-day MA of 134.74, and equal to the 200-day MA of 115.54, indicating a bullish trend. The MACD of 0.63 indicates Positive momentum. The RSI at 52.95 is Neutral, neither overbought nor oversold. The STOCH value of 51.81 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for XHS.
XHS Peer Comparison
Comparison Results
Performance Comparison
XHS
SPDR S&P Health Care Services ETF
135.61
36.06
36.22%
RSPH
Invesco S&P 500 Equal Weight Health Care ETF
―
―
―
XPH
SPDR S&P Pharmaceuticals ETF
―
―
―
PJP
Invesco Dynamic Pharmaceuticals ETF
―
―
―
PBE
Invesco Dynamic Biotechnology & Genome ETF
―
―
―
PINK
Simplify Health Care ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents